VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Studies show that ZHX2 could be used as a potential therapeutic target for ccRCC.07/20/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology